Business · 06/10/2026Updated: 10/17/2026 · 1 min read
Teva Pharmaceuticals USA, Inc., et al.; Withdrawal of Approval of 15 Abbreviated New Drug Applications; Correction
Summary
The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register on May 7, 2026, regarding the withdrawal of approval of 15 abbreviated new drug applications (ANDAs) from Teva Pharmaceuticals USA, Inc., et al.
Original source language: Federal Register — Health and Human ServicesOpen original release →